Klothea Bio, Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-09-08.
Klothea Bio, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on September 8, 2026. The filing reports $6.88M sold. Its industry group is Other Health Care. It names Jeffrey Madden (Executive Officer, Director), Agustin Fernandez Santana III (Executive Officer, Director), Olivier Jarry (Executive Officer) (SEC Form D/A, September 8, 2026).
Sell to companies like Klothea Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-09-08 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Klothea Bio, Inc.
Free to see. No signup.
More on the people and the money behind Klothea Bio, Inc., from the filings we hold.
Other Health Care raises by companies based in Florida, filed in September 2026, largest first.
Get an email when Klothea Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Klothea Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Klothea Bio, Inc. →Get the full cited report on Klothea Bio, Inc.
What the filing shows about Klothea Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Klothea Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Klothea Bio, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $6.88M, on the same scale — one filing against the whole group's total, so it sits low by construction.
By form type: D/A ×3 · D ×1.
What the filing shows about Klothea Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Klothea Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Klothea Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The 4 most recent of 4 filings on CIK 0002042705, filed as Klothea Bio, Inc.. Read from the SEC's own submissions feed for this issuer, not from a third party. Incorporated in DE. Full history on sec.gov.
Jeffrey Madden is named as Executive Officer and Director on the Form D that Klothea Bio, Inc. filed with the SEC on 8 September 2026, one of 5 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
Agustin Fernandez Santana III is named as Executive Officer and Director on the Form D that Klothea Bio, Inc. filed with the SEC on 8 September 2026, one of 5 people that filing names.
Olivier Jarry is named as Executive Officer on the Form D that Klothea Bio, Inc. filed with the SEC on 8 September 2026, one of 5 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
Walter Schmidt is named as Director on the Form D that Klothea Bio, Inc. filed with the SEC on 8 September 2026, one of 5 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
Petr Sramek is named as Director on the Form D that Klothea Bio, Inc. filed with the SEC on 8 September 2026, one of 5 people that filing names.
Public records were searched under this name on 10 September 2026 — the federal exclusions list and SEC investment-adviser registration, including that register's own disclosure flag. Nothing came back. Names repeat and nothing here was matched on an identifier, so this is not a background check, and an absence from a register is not a clearance.
5 people named on the filing — 3 holding an executive role and 2 as directors only.
Named as of the 2026-09-08 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Klothea Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Klothea Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Klothea Bio, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/klothea-bio-inc-form-d-000005